Abeona Therapeutics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABEO Nasdaq 2836 www.abeonatherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 2nd, 2026 5:30 am
Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright - Sep 22nd, 2026 4:02 pm
Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum - Sep 22nd, 2026 2:02 am
Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA) - Sep 18th, 2026 5:30 am
ABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It Sells - Sep 17th, 2026 5:33 pm
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday - Sep 16th, 2026 7:17 am
Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN® - Sep 16th, 2026 5:30 am
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - Sep 2nd, 2026 5:30 am
Abeona’s (ABEO) Gene Therapy Launch Hits A Pivotal Reimbursement Milestone - Aug 21st, 2026 9:42 am
Abeona Therapeutics Inc (ABEO) (Q2 2026) Earnings Call Highlights: ZEVASKYN Revenue Surges 31% ... - Aug 17th, 2026 1:03 pm
ABEO: Zevaskyn® Launch Gains Momentum - Aug 17th, 2026 9:05 am
Abeona Therapeutics Inc. Q2 2026 Earnings Call Summary - Aug 13th, 2026 2:56 pm
Abeona Therapeutics Q2 Earnings Call Highlights - Aug 13th, 2026 8:05 am
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update - Aug 13th, 2026 5:30 am
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 - Aug 6th, 2026 5:30 am
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN® - Aug 4th, 2026 5:30 am
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN® - Jul 21st, 2026 5:30 am